EUVIMEDEUVIMED entdecken
Crossref

Synthetic Benzylic Diselenides and Disulfides: Potential Anticancer Activities via Modulation of the ROS‐Dependent Akt/β‐Catenin Signaling Pathway

Pallavi Barman iD, Roopjyoti Misra iD, Nikita Pal iD, Shilpi Sarkar iD, Krishna P Bhabak iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Pallavi Barman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati, Assam, 781039, India. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Antineoplastic Agents, beta Catenin, Reactive Oxygen Species. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: ICMR, SERB, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The natural and synthetic organodiselenides have garnered much research attention due to their chemotherapeutic and chemopreventive activities. Herein, we describe the synthesis of a series of benzylic diselenides, which were synthesized by coupling the in situ generated disodium diselenide with the corresponding benzylic halides. The diselenides were evaluated for their anticancer activities in the highly aggressive triple‐negative breast cancer cells. Preliminary anti‐proliferative activities indicated 4‐cyano‐substituted diselenide 7 to be most potent with an IC 50 value of 1.9±0.3 μM. Detailed mechanistic investigations showed that diselenide 7 induces apoptosis and causes G1 phase arrest of the cell cycle. It exhibits anticancer activity by suppressing the Akt/β‐catenin signaling pathway. Further control experiments with LiCl (inhibitor of GSK‐3β) revealed that down‐regulation of β‐catenin was promoted by GSK‐3β‐induced phosphorylation of β‐catenin and its subsequent proteasomal degradation. Moreover, the intracellular ROS was found to act as an upstream mediator for the inactivation of the Akt/β‐catenin signaling pathway. The present study describing the efficient anticancer activity of a synthetic benzylic diselenide towards triple‐negative breast cancer cells through the modulation of ROS‐dependent Akt/β‐catenin signaling pathway would certainly be helpful in the future towards the development of small‐molecule organoselenium compounds for the treatment of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktAntineoplastic Agentsbeta CateninReactive Oxygen SpeciesCell ProliferationApoptosisSignal TransductionDrug Screening Assays, AntitumorHumansOrganoselenium CompoundsStructure-Activity RelationshipCell Line, TumorMolecular StructureDose-Response Relationship, DrugTriple Negative Breast Neoplasms

Stichwörter der Autor:innen

Akt/β-cateninGSK-3βOrganodiselenides and disulfidesROSTriple-negative breast cancer

Substanzen

Proto-Oncogene Proteins c-aktAntineoplastic Agentsbeta CateninReactive Oxygen SpeciesOrganoselenium Compounds

Autor:innen und Institutionen

  • Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati, Assam, 781039, India.
  • Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, 781039, India.

ORCID-Profile: Pallavi Barman, Roopjyoti Misra, Nikita Pal, Shilpi Sarkar, Krishna P Bhabak

Förderung

  • ICMR
  • SERB
  • Indian Council of Medical Research
  • Science and Engineering Research Board

Zitieren

APA

Barman, P., Misra, R., Pal, N., Sarkar, S., & Bhabak, K. P. (2024). Synthetic Benzylic Diselenides and Disulfides: Potential Anticancer Activities via Modulation of the ROS‐Dependent Akt/β‐Catenin Signaling Pathway. ChemMedChem. https://doi.org/10.1002/cmdc.202400358

Vancouver

Barman P, Misra R, Pal N, Sarkar S, Bhabak KP. Synthetic Benzylic Diselenides and Disulfides: Potential Anticancer Activities via Modulation of the ROS‐Dependent Akt/β‐Catenin Signaling Pathway. ChemMedChem. 2024. doi:10.1002/cmdc.202400358

BibTeX
@article{Barman2024,
  author = {Barman, Pallavi and Misra, Roopjyoti and Pal, Nikita and Sarkar, Shilpi and Bhabak, Krishna P},
  title = {Synthetic Benzylic Diselenides and Disulfides: Potential Anticancer Activities via Modulation of the ROS‐Dependent Akt/β‐Catenin Signaling Pathway},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400358}
}
Kostenlos starten →